News
First EDCTP and Africa CDC-supported Epidemiologists and Biostatisticians start their training
The European & Developing Countries Clinical Trials Partnership (EDCTP) and the Africa Centres for Disease Control and Prevention (Africa CDC) are partnering to train 150…
RTS,S/AS01 malaria vaccine: EDCTP contributions and next steps
EDCTP has supported the development of the RTS,S/AS01 malaria vaccine both directly and indirectly through funding clinical research and capacity strengthening in Mozambique, Tanzania, Kenya,…
African Union and EDCTP sign Memorandum of Understanding to promote new paradigm in health
The African Union (AU) through the African Centres for Disease Control and Prevention (Africa CDC), and the European and Developing Countries Clinical Trials Partnership (EDCTP)…
Recommendations from the EDCTP/ECRIN session on clinical trial infrastructure and capacity building in Africa
The European Clinical Infrastructure Networks (ECRIN) and EDCTP hosted a session on clinical trial infrastructure and capacity building in Africa at the Africa-Europe Science and…
Biofabri and IAVI announce partnership to advance MTBVAC into efficacy trials
Biofabri and IAVI have announced their intention to partner on efficacy trials of the tuberculosis (TB) vaccine candidate MTBVAC. This highly promising vaccine candidate has…
Annual Report 2020 - focused delivery on promises
EDCTP’s Annual Report 2020 summarises the activities of the Partnership in 2020, shows the steady growth, scope and cohesion of the project portfolio, and highlights…
EDCTP principal investigators receive Queen’s Birthday Honours
On 11 June, the Queen’s Birthday Honours List 2021 was announced, this year’s list includes researchers that have played key roles in the response to…
IAVI led consortium receives EDCTP and CEPI funding for a large-scale clinical trial of Lassa fever vaccine candidate
IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations…
New support tools for TB vaccine R&D published
The Tuberculosis Vaccine Initiative (TBVI) has coordinated the development of several new tools to support future TB vaccine clinical trials. Experts in the field together with…
Call for abstracts for the Tenth EDCTP Forum
The 10th EDCTP Forum will be held as a virtual meeting hosted from the Joaquin Chissano International Conference Centre in Maputo from 17-20 October 2021. The Forum…
World Malaria Day 2021
On World Malaria Day 2021, EDCTP joins all partners in the ‘Zero Malaria – Draw the Line Against Malaria’ campaign towards the goal of malaria…
EDCTP-funded trial of R21/Matrix-M malaria vaccine shows efficacy of 77%
Positive results from an EDCTP-funded clinical trial in Burkina Faso, published as a preprint with The Lancet, demonstrate that the malaria vaccine candidate R21/Matrix-M is…
EDCTP and AIGHD launched a global roadmap for tuberculosis vaccine development
On 20 April 2021, EDCTP and the Amsterdam Institute for Global Health and Development (AIGHD) have launched a global TB vaccine R&D roadmap at the…
World TB Day: the promise of ending the TB epidemic
World TB Day puts the spotlight on tuberculosis (TB), a poverty-related infectious disease of epidemic proportions. Currently, it causes more deaths than any other infectious…
International Women’s Day 2021: a challenge to inequality
In her statement for International Women’s Day 2021, Winnie Byanyima, the Executive Director of UNAIDS and Under-Secretary-General of the United Nations, focused on inequality in…